Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial.

ABSTRACT:

SUBMITTER: Durie BGM 

PROVIDER: S-EPMC5546834 | biostudies-literature | 2017 Feb

REPOSITORIES: biostudies-literature